Chris Howerton

Stock Analyst at Jefferies

(4.2)
# 1672
Out of 5,446 analysts
100
Total ratings
Success rate
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
ARDX Ardelyx
Maintains: Buy
11 8
5.99 33.56% 5 Jan 2, 2025
GPCR Structure Therapeuti...
Maintains: Strong Buy
50 79
18.57 325.42% 2 Sep 29, 2023
PNT POINT Biopharma Glob...
Assumes: Strong Buy
12 14
12.5 12% 3 Jul 20, 2023
MIST Milestone Pharmaceut...
Downgrades: Hold
8 4
1.64 143.9% 4 Jun 20, 2023
VERU Veru
Upgrades: Hold
10
3.53 183.29% 3 Jun 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25
24.98 0.08% 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
320 352
5.02 6911.95% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1 1
n/a n/a 3 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
720
9.22 7709.11% 2 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
1.44 -65.28% 2 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 10
19.31 -48.21% 1 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
8 2
4.59 -56.43% 3 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
2 1
22.93 -95.64% 3 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
16.87 6.7% 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7 11
14.25 -22.81% 3 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
30 20
39.95 -49.94% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
70 40
26.58 50.49% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
57 61
36.63 66.53% 3 Oct 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 90
117 -23.08% 3 Sep 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
870 510
n/a n/a 2 Apr 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 183
329.83 -44.52% 2 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 2
1.35 11.11% 2 Mar 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
24 12
4.6 160.87% 5 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
100
99.99 0.01% 3 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
101 126
1.27 9821.26% 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
1.88 963.83% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
66
20.89 215.94% 4 Sep 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
n/a n/a 1 Aug 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
5.58 294.27% 1 Aug 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
1.7 1135.29% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
1.24 1674.19% 1 May 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
n/a n/a 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
1.52 1413.16% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
220 360
n/a n/a 3 Apr 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
40 21
24.94 -15.8% 4 Apr 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 5
n/a n/a 2 Mar 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
6
n/a n/a 3 Dec 10, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 88
n/a n/a 2 Sep 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Aug 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
n/a n/a 1 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
80 580
17.94 3133% 2 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
63 60
1.11 5305.41% 1 Aug 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
16
70.4 -77.27% 2 Aug 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
56.23 -51.98% 1 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
1200
6.94 17191.07% 1 May 26, 2020